# Catalent Pharma Solutions Limited – FDA Inspection, Feb 20, 2020

Source: https://www.keypedia.com/records/fda_inspections/catalent-pharma-solutions-limited/d589f12b-d6fc-49b3-8690-e8f522afef3e
Source feed: FDA_Inspections

> FDA inspection 1141164 of Catalent Pharma Solutions Limited, February 20, 2020. Classification: Voluntary Action Indicated (VAI). 9 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1141164
- Company Name: Catalent Pharma Solutions Limited
- Inspection Date: 2020-02-20
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1267053 - 2024-10-10
- FDA Inspection 1261182 - 2023-06-15
- [FDA Inspection 1065786 - 2018-08-23](https://www.keypedia.com/records/fda_inspections/catalent-pharma-solutions-limited/42adcb22-d2e8-4784-abfc-f8f095cc2170)
- [FDA Inspection 1064287 - 2018-07-26](https://www.keypedia.com/records/fda_inspections/catalent-pharma-solutions-limited/e34de78c-e636-48d1-8b8a-9184de29130e)
- [FDA Inspection 1048918 - 2018-04-20](https://www.keypedia.com/records/fda_inspections/catalent-pharma-solutions-limited/9a66178c-e371-4567-b385-4a256196a668)

Company: https://www.keypedia.com/companies/catalent-pharma-solutions-limited/99911e93-f0af-406d-9968-0634cf809ce4

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c